Alliance Pharma PLC, a healthcare group, has issued a notification regarding its total voting rights in accordance with the UK Financial Conduct Authority's Disclosure and Transparency Rule 5.6.1. As of 30 June 2024, the company's issued share capital consists of 540,565,539 Ordinary Shares of 1p each, and the total number of voting rights in the company is 540,565,539. Shareholders can use this figure as the denominator for the calculations to determine if they are required to notify their interest in the company under the FCA's Disclosure Guidance and Transparency Rules.

Alliance Pharma PLC, listed on AIM, is a growing consumer healthcare company with the purpose of empowering people to make a positive difference to their health and wellbeing by making trusted and proven brands available worldwide. The company focuses on delivering organic growth through investing in priority brands and channels, related innovation, and selective geographic expansion to increase the reach of its brands. Additionally, the company may consider enhancing its organic growth through selective, complementary acquisitions.

For further information, interested parties can contact Alliance Pharma PLC through the provided contact details.

This notification provides shareholders and the public with an update on the company's total voting rights and its commitment to delivering organic growth and expanding its reach through strategic investments and potential acquisitions.